NCT00627276View on ClinicalTrials.gov

Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

December 31, 2012

Study Completion Date

November 30, 2013

Conditions
Breast CancerPrecancerous Condition
Interventions
DIETARY_SUPPLEMENT

omega-3 fatty acid

Oral, 3 times daily

OTHER

placebo

Oral, 3 times daily

Trial Locations (2)

97220

Epic Imaging, Portland

97239-3098

Knight Cancer Institute at Oregon Health and Science University, Portland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

OHSU Knight Cancer Institute

OTHER

NCT00627276 - Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia | Biotech Hunter | Biotech Hunter